Sitemap
Medical science
08/2006 Maturation of the autonomic nervous system: differences in heart rate variability in premature vs. term infants
08/2006 Four chamber view plus three-vessel and trachea view for a complete evaluation of the fetal heart during the second trimester
08/2006 Pleural fluid/serum immunoglobulin ratio is a diagnostic marker for congenital chylothorax in utero
08/2006 Fetal brain sparing is strongly related to the degree of increased placental vascular impedance
08/2006 Outcome of fetuses in women with pregestational diabetes mellitus
08/2006 Inhaled nitric oxide therapy might reduce the need for hyperventilation therapy in infants with persistent pulmonary hypertension of the newborn
08/2006 To drain or not to drain: a single institution experience with neonatal intestinal perforation
08/2006 Infective puerperal endocarditis caused by Escherichia coli
08/2006 Correlation between plasma and urinary caffeine levels in preterm infants
08/2006 Adiponektin, ein Adipokin mit großem Potenzial für Diagnostik und Therapie des metabolischen Syndroms und assoziierter kardiovaskulärer Erkrankungen / Adiponectin, an adipokine as a promising target for diagnosis and therapy of the metabolic syndrome and
08/2006 Bedeutung von Chrom, Kupfer, Selen und Zink bei Diabetes mellitus Typ 1 und Typ 2 mit Folgeerkrankungen / Importance of chromium, copper, selenium and zinc in diabetes mellitus type 1 and type 2 with late disease
08/2006 Die medizinische Bedeutung von Selen / The clinical relevance of selenium
08/2006 Patientennahe Diagnostik in Krisensituationen / Near patient testing in exceptional situations
08/2006 Influenza rapid tests – advantages and limitations
08/2006 CE-Kennzeichnung von Point-of-Care-Testsystemen / CE marking of point-of-care test devices
08/2006 Rechtssicherheit von Point-of-Care-Tests / Legal certainty of point-of-care tests
08/2006 Diagnosekriterien für das Antiphospholipid-Syndrom (APS) / Diagnostic criteria for the antiphospholipid syndrome (APS)
08/2006 Diagnostik bei autoimmunen Schilddrüsenerkrankungen / Diagnostic testing for autoimmune thyroid diseases
09/2006 Initial treatment of venous thromboembolism
09/2006 Role of fibrinolysis and interventional therapy for acute venous thromboembolism
09/2006 New concepts in optimal management of anticoagulant therapy for extended treatment of venous thromboembolism
09/2006 Racial and gender differences in the incidence of recurrent venous thromboembolism
09/2006 Emerging anticoagulants for the treatment of venous thromboembolism
09/2006 Preeclampsia and pregnancy loss in women with a history of venous thromboembolism and prophylactic low-molecular-weight heparin (LMWH) during pregnancy
09/2006 Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide
09/2006 Amino acid regions 572579 and 657666 of the spacer domain of ADAMTS13 provide a common antigenic core required for binding of antibodies in patients with acquired TTP
09/2006 Identification of a new truncated form and deamidation products of fibrinopeptide B released by thrombin from human fibrinogen
09/2006 Recombinant factor VIII and factor VIII-von Willebrand factor complex do not present danger signals for human dendritic cells
09/2006 Amplified anticoagulant activity of tissue factor-targeted thrombomodulin. In-vivo validation of a tissue factor-neutralizing antibody fused to soluble thrombomodulin
09/2006 Fibrinolytic efficacy of Amediplase, Tenecteplase and scu-PA in different external plasma clot lysis models. Sensitivity to the inhibitory action of thrombin activatable fibrinolysis inhibitor (TAFI)
09/2006 Haplotypes of the plasminogen activator gene associated with ischemic stroke
09/2006 Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity
09/2006 Folic acid administration and antibodies against homocysteinylated proteins in subjects with hyperhomocysteinemia
09/2006 Psychological impact of testing for thrombophilic alterations
09/2006 Identification of functional polymorphisms of the thromboxane A2 receptor gene in healthy volunteers
09/2006 A novel mechanism of transcriptional repression of p27kip1 through Notch/HRT2 signaling in vascular smooth muscle cells
09/2006 Antithrombin is as effective as heparin and hirudin to prevent formation of microvascular thrombosis in a murine model
09/2006 Isolated medial meniscal tear in a Border Collie
09/2006 An oxygen imaging system for medical applications: preliminary results
09/2006 Erste Ergebnisse zur Untersuchung der Stabilität und Gewebeintegration eines abbaubaren, elastischen Copolymers im Tiermodell / First results of the investigation of the stability and tissue integration of a degradable, elastomeric copolymer in an animal
09/2006 Entwicklung eines Operationsgerätes zur minimal-invasiven Fascia lata-Entnahme / Designing a surgical device for harvesting autologous fascia lata grafts as a minimal invasive procedure
09/2006 Analyse der periprothetischen femoralen Knochenreaktion nach zementfreier Hüftendoprothetik mittels computertomographiegestützter Osteodensitometrie in vivo: 6-Jahres-Follow-up / Analysis of the periprosthetic femoral bone reaction after
09/2006 Der Einfluss der Patellakinematik auf die tibiale Rotation nach Knie-Totalendoprothesen-Implantation / Influence of patellar position on tibial rotation after total knee arthroplasty
09/2006 Der Einfluss von Laserlichtbestrahlung niedriger Leistungsdichte auf einen experimentellen Knorpelschaden im Kniegelenk des Kaninchens: eine in vivo-Untersuchung unter Berücksichtigung makroskopischer, histologischer und immunhistochemisc
09/2006 A long and winding road: defining the biological role and clinical importance of paraoxonases
09/2006 Point-of-care testing in the cardiovascular operating theatre
09/2006 Low-density lipoprotein receptor-related protein 5 and vitamin D receptor gene polymorphisms in relation to vitamin D levels in menopause
09/2006 The methylenetetrahydrofolate reductase C677T gene mutation is associated with hyperhomocysteinemia, cardiovascular disease and plasma B-type natriuretic peptide levels in Korea
09/2006 Exploring allelic imbalance within paraffin-embedded tumor biopsies using pyrosequencing technology
09/2006 Detection of circulating tumour cells in blood by quantitative real-time RT-PCR: effect of pre-analytical time
09/2006 Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe
09/2006 Molecular assay for detection of the common carnitine palmitoyltransferase 1A 1436(C>T) mutation
09/2006 Serum cytokine levels and the expression of estrogen and progesterone receptors in breast cancer patients
09/2006 Protein Z levels and prognosis in patients with acute coronary syndromes
09/2006 Determination of total bilirubin in whole blood from neonates: results from a French multicenter study
09/2006 Analysis of protein S-100B in serum: a methodological study
09/2006 Lipid peroxidation and homocysteine levels in Behçet's disease
09/2006 Lower expression of the ?2,3-sialylated fibronectin glycoform and appearance of the asialo-fibronectin glycoform are associated with high concentrations of fibronectin in human seminal plasma with abnormal semen parameters
09/2006 Automated processing of whole blood samples for the determination of immunosuppressants by liquid chromatography tandem-mass spectrometry
09/2006 Role of methionine residues of albumin in T-R conversion of hemoglobin
09/2006 Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9)
09/2006 Significance of Elecsys® S100 immunoassay for real-time assessment of traumatic brain damage in multiple trauma patients
09/2006 IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37°C: International Federation of Clinical Chemistry and Laboratory Medicine (IFCC): Scientific Division, Committee on Reference Systems for Enzymes (
10/2006 The pharmacology of selective inhibition of COX-2
10/2006 COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies
10/2006 Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic anti-inflammatory drugs? Arguments in favor
10/2006 Does a coxib-associated thrombotic risk limit the clinical use of the compounds as analgesic, antiinflammatory drugs? Arguments against
10/2006 Transcription-based COX-2 inhibition: A therapeutic strategy
10/2006 Selective COX-2 inhibitors and risk of thromboembolic events regulatory aspects
10/2006 Evidence for the benefits of prophylaxis in the management of hemophilia A
Back
Search
